相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dual inhibition of cannabinoid CB1 receptor and inducible NOS attenuates obesity-induced chronic kidney disease
Shiran Udi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Predicting the Blood-Brain Barrier Permeability of New Drug-Like Compounds via HPLC with Various Stationary Phases
Malgorzata Janicka et al.
MOLECULES (2020)
The therapeutic potential of second and third generation CB1R antagonists
Resat Cinar et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Federica Zatterale et al.
FRONTIERS IN PHYSIOLOGY (2020)
The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders
J. Maia et al.
HUMAN REPRODUCTION UPDATE (2020)
Anti-obesity therapy with peripheral CB1 blockers: from promise to safe(?) practice
Carmelo Quarta et al.
INTERNATIONAL JOURNAL OF OBESITY (2020)
Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
Patrycja Bielawiec et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
Michael A. Ueberall
JOURNAL OF PAIN RESEARCH (2020)
Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs
Thomas Murphy et al.
BIOMOLECULES (2020)
Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research
Danielle McCartney et al.
SPORTS MEDICINE-OPEN (2020)
Changing the tone of clinical study design in the cannabis industry
Joseph M. Antony et al.
TRANSLATIONAL NEUROSCIENCE (2020)
A patent update on cannabinoid receptor 1 antagonists (2015-2018)
George Amato et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Medical marijuana-an obesity problem or opportunity?
Frank L. Greenway et al.
INTERNATIONAL JOURNAL OF OBESITY (2019)
Insulin analogs: Glimpse on contemporary facts and future prospective
Arun K. Sharma et al.
LIFE SCIENCES (2019)
Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Arulkumar Nagappan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Serena Silvestro et al.
MOLECULES (2019)
Development of Oxygen-Bridged Pyrazole-Based Structures as Cannabinoid Receptor 1 Ligands
Gabriele Murineddu et al.
MOLECULES (2019)
Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome
Shira Hirsch et al.
TOXINS (2019)
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development
Thuy Nguyen et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes
Ruth C. R. Meex et al.
OBESITY REVIEWS (2019)
Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
Joshua D. Brown et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Adipose Tissue-Derived Signatures for Obesity and Type 2 Diabetes: Adipokines, Batokines and MicroRNAs
Min-Woo Lee et al.
JOURNAL OF CLINICAL MEDICINE (2019)
New insights into different adipokines in linking the pathophysiology of obesity and psoriasis
Yi Kong et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Cannabinoid CB1 Receptors Inhibit Gut-Brain Satiation Signaling in Diet-Induced Obesity
Donovan A. Argueta et al.
FRONTIERS IN PHYSIOLOGY (2019)
Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities
Szymon Hryhorowicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b)
Pratishtha Singh et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow
Jie Wu
ACTA PHARMACOLOGICA SINICA (2019)
Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk
Manuel F. Landecho et al.
NUTRIENTS (2019)
The Latest Insights into Adipokines in Diabetes
Won Kon Kim et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis
Vijay Pralhad Kale et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2019)
The therapeutic potential of targeting the peripheral endocannabinoid/CB1 receptor system
Joseph Tam et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Combined and individual strategy of exercise generated preconditioning and low dose copper nanoparticles serve as superlative approach to ameliorate ISO-induced myocardial infarction in rats
Arun K. Sharma et al.
PHARMACOLOGICAL REPORTS (2018)
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Ila M. P. Linares et al.
FRONTIERS IN PHARMACOLOGY (2018)
Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists
Pankaj Pandey et al.
MOLECULES (2018)
Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis
Malliga R. Iyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Debra A. Kendall et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis
Resat Cinar et al.
JCI INSIGHT (2017)
Albiglutide: Is a better hope against diabetes mellitus?
Arun K. Sharma et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
A. Vanessa Stempel et al.
NEURON (2016)
Endocannabinoid signaling at the periphery: 50 years after THC
Mauro Maccarrone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Prediabetes: grounds of pitfall signalling alteration for cardiovascular disease (vol 4, pg 58272, 2014)
Sameer N. Goyal et al.
RSC ADVANCES (2015)
Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat
Harald S. Hansen
PHARMACOLOGICAL RESEARCH (2014)
Mechanism linking diabetes mellitus and obesity
Abdullah S. Al-Goblan et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2014)
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9-tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats
Erin M. Rock et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
E. T. Wargent et al.
NUTRITION & DIABETES (2013)
The dysregulation of the endocannabinoid system in diabesity-a tricky problem
Thomas Scherer et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Hypothalamic Control of Hepatic Glucose Production and Its Potential Role in Insulin Resistance
Christoph Buettner et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms
Christoph Buettner et al.
NATURE MEDICINE (2008)
Brain-adipose tissue cross talk
TJ Bartness et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2005)
分享论文
